Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesley R Badger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Tetrahedron Letters|March 6, 2010
Nucleophilic cationization reagentsSouvik Biswas, Xuan Huang, Wesley R Badger, et al.
American Journal of Surgery|December 18, 2016
Utility of MRCP in clinical decision making of suspected choledocholithiasis: An institutional analysis and literature reviewWesley R Badger, Andrew J Borgert, Kara J Kallies, et al.
BMC Cancer|December 15, 2011
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanomaSucheta Telang, Mary Ann Rasku, Amy L Clem, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Tetrahedron Letters|March 6, 2010
Nucleophilic cationization reagentsSouvik Biswas, Xuan Huang, Wesley R Badger, et al.
American Journal of Surgery|December 18, 2016
Utility of MRCP in clinical decision making of suspected choledocholithiasis: An institutional analysis and literature reviewWesley R Badger, Andrew J Borgert, Kara J Kallies, et al.
BMC Cancer|December 15, 2011
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanomaSucheta Telang, Mary Ann Rasku, Amy L Clem, et al.
Pageof 1